Mural Oncology plc, (Nasdaq: MURA) (“Mural”), a clinical-stage immuno-oncology company, today announces for the purposes of the Irish Takeover Panel Act, 1997, Takeover Rules 2022 (the “Irish Takeover ...
FLINT Corp. ("FLINT" or the "Company") (TSX: FLNT) is pleased to announce the completion of its recapitalization transaction ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback